Ganciclovir and Colace drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ganciclovir (ganciclovir) and Colace (docusate ). Common drug interactions include blood creatinine increased among females and pericardial effusion among males.

The phase IV clinical study analyzes what interactions people have when they take Ganciclovir and Colace. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Ganciclovir?

Ganciclovir has active ingredients of ganciclovir. eHealthMe is studying from 6,370 Ganciclovir users. Check the latest studies of Ganciclovir.

What is Colace?

Colace has active ingredients of docusate . It is often used in constipation. eHealthMe is studying from 41,841 Colace users. Check the latest studies of Colace.



On Jul, 12, 2026

37 people who take Ganciclovir and Colace together, and have interactions are studied.

Ganciclovir and Colace drug interactions.

What are the common drug interactions of Ganciclovir and Colace, by gender? *:

female:

  1. Blood creatinine increased
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  4. Hepatic function abnormal
  5. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  6. Large intestine perforation (hole in large intestine)
  7. Pneumocystis carinii pneumonia (pneumonia occurring in infants or in persons with impaired immune systems)
  8. Pyrexia (fever)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Abdominal pain lower

male:

  1. Pericardial effusion (fluid around the heart)
  2. Pyrexia (fever)
  3. Emotional distress
  4. Pain
  5. Pleural effusion (water on the lungs)
  6. Pneumonia
  7. Chest tightness
  8. Hypoxia (low oxygen in tissues)
  9. Productive cough
  10. Rib fracture

What are the common drug interactions of Ganciclovir and Colace, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Agitation (state of anxiety or nervous excitement)
  2. Apnoea (suspension of external breathing)
  3. Cardiac arrest
  4. Cardiac failure congestive
  5. Haematocrit increased
  6. Haematoma (collection of blood outside the blood vessels)
  7. Haemorrhage (bleeding)
  8. Mediastinal disorder (disease of mediastinum)
  9. Myoclonic jerks (involuntary twitching of a muscle or group of muscles)
  10. Nausea (feeling of having an urge to vomit)

20-29:

  1. Abdominal distension
  2. Abscess (pus)
  3. Chronic kidney disease
  4. Cytomegalovirus infection
  5. Emotional distress
  6. Kidney transplant rejection
  7. Pain
  8. Pancreatic disorder
  9. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  10. Renal failure (kidney dysfunction)

30-39:

n/a

40-49:

  1. Graft rejection (graft failure)
  2. Hepatic function abnormal
  3. Hyperglycaemia (high blood sugar)
  4. Hyperkalaemia (damage to or disease of the kidney)
  5. Hypersensitivity
  6. Hypokalaemia (low potassium)
  7. Hypotension (abnormally low blood pressure)
  8. Lipase increased
  9. Myositis (inflammation of the muscles)
  10. Nasopharyngitis (inflammation of the nasopharynx)

50-59:

  1. Pericardial effusion (fluid around the heart)
  2. Atelectasis (partial or complete collapse of the lung)
  3. Dyspnoea (difficult or laboured respiration)
  4. Abdominal distension
  5. Ileus (a painful obstruction of the ileum or other part of the intestine)
  6. Pyrexia (fever)
  7. Oxygen saturation decreased
  8. Pleural effusion (water on the lungs)
  9. Pneumonia
  10. Chest tightness

60+:

  1. Anaemia (lack of blood)
  2. Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
  3. Dyspnoea (difficult or laboured respiration)
  4. Epistaxis (bleed from the nose)
  5. Gallbladder oedema (swelling of gallbladder)
  6. Graft versus host disease in intestine (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body and damages intestinal mucosal membrane)
  7. Haematocrit decreased
  8. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  9. Hypoglycaemia (deficiency of glucose in the bloodstream)
  10. Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

  1. Pain: 3 people, 8.11%
  2. Hiv Infection: 3 people, 8.11%
  3. Type 1 Diabetes: 2 people, 5.41%
  4. Transplant Rejection (a transplant material is not worked): 2 people, 5.41%
  5. Sleep Disorder: 2 people, 5.41%
  6. Oedema (fluid collection in tissue): 2 people, 5.41%
  7. Nausea (feeling of having an urge to vomit): 2 people, 5.41%
  8. Multiple Myeloma (cancer of the plasma cells): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Ganciclovir and Colace?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ganciclovir and Colace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ganciclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Colace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ganciclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Colace and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ganciclovir and docusate (the active ingredients of Ganciclovir and Colace, respectively), and Ganciclovir and Colace (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: